Ostapchuk Philomena, Yang Jihong, Auffarth Ece, Hearing Patrick
Department of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
J Virol. 2005 Mar;79(5):2831-8. doi: 10.1128/JVI.79.5.2831-2838.2005.
Adenovirus type 5 (Ad5) DNA packaging is initiated in a polar fashion from the left end of the genome. The packaging process is dependent on the cis-acting packaging domain located between nucleotides 230 and 380. Seven AT-rich repeats that direct packaging have been identified within this domain. A1, A2, A5, and A6 are the most important repeats functionally and share a bipartite sequence motif. Several lines of evidence suggest that there is a limiting trans-acting factor(s) that plays a role in packaging. Both cellular and viral proteins that interact with adenovirus packaging elements in vitro have been identified. In this study, we characterized a group of recombinant viruses that carry site-specific point mutations within a minimal packaging domain. The mutants were analyzed for growth properties in vivo and for the ability to bind cellular and viral proteins in vitro. Our results are consistent with a requirement of the viral IVa2 protein for DNA packaging via a direct interaction with packaging sequences. Our results also indicate that higher-order IVa2-containing complexes that form on adjacent packaging repeats in vitro are the complexes required for the packaging activity of these sites in vivo. Chromatin immunoprecipitation was used to study proteins that bind directly to the packaging sequences. These results demonstrate site-specific interaction of the viral IVa2 and L1 52/55K proteins with the Ad5 packaging domain in vivo. These results confirm and extend those previously reported and provide a framework on which to model the adenovirus assembly process.
5型腺病毒(Ad5)的DNA包装从基因组左端以极性方式起始。包装过程依赖于位于核苷酸230至380之间的顺式作用包装结构域。在该结构域内已鉴定出七个指导包装的富含AT的重复序列。A1、A2、A5和A6在功能上是最重要的重复序列,并共享一个二分序列基序。几条证据表明存在一种在包装中起作用的限制性反式作用因子。已鉴定出在体外与腺病毒包装元件相互作用的细胞和病毒蛋白。在本研究中,我们对一组在最小包装结构域内携带位点特异性点突变的重组病毒进行了表征。分析了这些突变体在体内的生长特性以及在体外结合细胞和病毒蛋白的能力。我们的结果与病毒IVa2蛋白通过与包装序列直接相互作用进行DNA包装的需求一致。我们的结果还表明,在体外相邻包装重复序列上形成的含IVa2的高阶复合物是这些位点在体内包装活性所需的复合物。使用染色质免疫沉淀来研究直接与包装序列结合的蛋白质。这些结果证明了病毒IVa2和L1 52/55K蛋白在体内与Ad5包装结构域的位点特异性相互作用。这些结果证实并扩展了先前报道的结果,并为模拟腺病毒组装过程提供了一个框架。